Growth hormone secretagogues. Clinical experience and therapeutic potential (Q40932299)

25 September 2017

1 reference

title

Growth hormone secretagogues. Clinical experience and therapeutic potential (English)

1 reference

25 September 2017

Z Laron

1

1 reference

25 September 2017

1 October 1995

1 reference

25 September 2017

1 reference

25 September 2017

50

1 reference

25 September 2017

4

1 reference

25 September 2017

595-601

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199550040-00002

25 September 2017

0 references

cites work

Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents

1 reference

12 December 2020

Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men

1 reference

12 December 2020

On the actions of the growth hormone-releasing hexapeptide, GHRP.

1 reference

12 December 2020

Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects

1 reference

12 December 2020

Effects of human growth hormone in men over 60 years old

1 reference

12 December 2020

Circadian variation of basal plasma growth hormone in man

1 reference

12 December 2020

Usefulness of the growth hormone-releasing hormone test regardless of which fragment is used (GHRH 1-44, 1-40 or 1-29).

1 reference

12 December 2020

Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly

1 reference

12 December 2020

Short Term Effect of Intranasal Administration of Hexarelin — A Synthetic Growth Hormone-Releasing Peptide. Preliminary Communication

1 reference

12 December 2020

Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal aging

1 reference

12 December 2020

GH releasing peptides--structure and kinetics

1 reference

12 December 2020

The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly

1 reference

12 December 2020

Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.

1 reference

12 December 2020

Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites

1 reference

12 December 2020

Evidence for a Role of Protein Kinase-C in His-D-Trp Ala-Trp-D-Phe-Lys-NH2-Induced Growth Hormone Release from Rat Primary Pituitary Cells

1 reference

12 December 2020

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

1 reference

12 December 2020

Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin)

1 reference

12 December 2020

Optimum use of growth hormone in children

1 reference

12 December 2020

Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential

1 reference

12 December 2020

Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors

1 reference

12 December 2020

Growth hormone releasing hormone (GH-RH, GRF)--an important new clinical tool

1 reference

12 December 2020

GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats

1 reference

12 December 2020

Neuroendocrine regulation of growth hormone.

1 reference

12 December 2020

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture

1 reference

12 December 2020

Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro

1 reference

12 December 2020

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

1 reference

12 December 2020

The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration

1 reference

12 December 2020

Intranasal administration of the GHRP hexarelin accelerates growth in short children

1 reference

12 December 2020

Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men

1 reference

12 December 2020

Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6

1 reference

12 December 2020

Growth hormone-releasing activity of hexarelin in humans. A dose-response study

1 reference

12 December 2020

A nonpeptidyl growth hormone secretagogue

1 reference

12 December 2020

Modalities of treatment for children with short stature

1 reference

12 December 2020

Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat

1 reference

12 December 2020

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

1 reference

12 December 2020

Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus

1 reference

12 December 2020

Design, Synthesis, and Biological Activity of Peptides which Release Growth Hormone in Vitro*

1 reference

12 December 2020

The therapeutic potential of recombinant human insulin-like growth factor-I.

1 reference

12 December 2020

Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6

1 reference

12 December 2020

10.2165/00003495-199550040-00002

Identifiers

DOI

1 reference

PubMed ID

8536548

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

8536548